New connections: Why emerging markets are winners of the 5G revolution

Spread of new technologies

clock • 2 min read

James Johnstone, co-head of emerging and frontier markets at RWC Partners, looks at the five companies he believes will benefit the most from the expansion of 5G technology.

James Johnstone, co-head of emerging and frontier markets at RWC Partners, looks at the five companies he believes will benefit the most from the expansion of 5G technology. Fifth generation cellular technology will revolutionise our lives and help us communicate digitally in a way we have never experienced before. Aside from being as much as 20x faster than current wireless internet, 5G technology will usher in an age of robots, smart vehicles and the Internet of Things (IoT). While the technology is still in its infancy, its use is set to increase dramatically, offering some inte...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot